{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:06:12Z","timestamp":1773291972675,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"13-14","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s10354-014-0288-7","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T05:53:34Z","timestamp":1406181214000},"page":"278-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Vitiligo: what\u2019s new in the psycho-neuro-endocrine-immune connection and related treatments","Vitiligo: Was gibt es Neues im Psycho-Neuro- Endokrino-Immunologischen Zusammenhang und bei verwandten Therapien?"],"prefix":"10.1007","volume":"164","author":[{"given":"Torello","family":"Lotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Zanardelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo Massimiliano","family":"D\u2019Erme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,25]]},"reference":[{"key":"288_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12103","volume":"22","author":"NC Laddha","year":"2013","unstructured":"Laddha NC, Dwivedi M, Mansuri MS, Gani AR, Ansarullah M, Ramachandran AV, Dalai S, Begum R. Vitiligo: interplay between oxidative stress and immune system. Experimental Dermatology. 2013;22:245\u201350.","journal-title":"Experimental Dermatology"},{"key":"288_CR2","doi-asserted-by":"crossref","unstructured":"Lotti T, Hercogova J, editors. Vitiligo: problems and solutions. New York: Marcel Dekker; 2004. S.\u00a0323\u201334.","DOI":"10.1201\/9781003039990"},{"issue":"1","key":"288_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","volume":"168","author":"A Taieb","year":"2013","unstructured":"Taieb A, Alomar A, B\u00f6hm M, Dell\u2019anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M. The writing group of the Vitiligo European Task Force (VETF) in cooperation with the European Academy of Dermatology and Venereology (EADV) and the Union Europ\u00e9enne des M\u00e9decins Sp\u00e9cialistes (UEMS). Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168(1):5\u201319.","journal-title":"Br J Dermatol"},{"issue":"3","key":"288_CR4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clindermatol.2013.11.011","volume":"32","author":"T Lotti","year":"2014","unstructured":"Lotti T, D\u2019Erme AM. Vitiligo: a systemic disease. Clin Dermatol. 2014;32(3):430\u201334.","journal-title":"Clin Dermatol"},{"issue":"Suppl 1","key":"288_CR5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/dth.12010","volume":"25","author":"J Hercogov\u00e1","year":"2012","unstructured":"Hercogov\u00e1 J, Schwartz RA, Lotti TM. Classification of vitiligo: a challenging endeavor. Dermatol Ther. 2012;25(Suppl 1):10\u20136.","journal-title":"Dermatol Ther"},{"issue":"3","key":"288_CR6","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","volume":"25","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, Goh BK, Anbar T, Silva de Castro C, Lee AY, Parsad D, van Geel N, Le Poole IC, Oiso N, Benzekri L, Spritz R, Gauthier Y, Hann SK, Picardo M, Taieb A. Vitiligo Global Issue Consensus Conference Panelists. Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25(3):E1\u201313.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"288_CR7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","volume":"16","author":"K Ongenae","year":"2003","unstructured":"Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003;16(2):90\u2013100.","journal-title":"Pigment Cell Res"},{"issue":"8","key":"288_CR8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archderm.144.8.1062","volume":"144","author":"MW Linthorst Homan","year":"2008","unstructured":"Linthorst Homan MW, Sprangers MA, de Korte J, Bos JD, van der Veen JP. Characteristics of patients with universal vitiligo and health-related quality of life. Arch Dermatol. 2008;144(8):1062\u20134.","journal-title":"Arch Dermatol"},{"issue":"5 Pt","key":"288_CR9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0190-9622(96)90718-5","volume":"35","author":"SK Hann","year":"1996","unstructured":"Hann SK, Lee HJ. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol. 1996;35(5 Pt 1):671\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"288_CR10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000131485","volume":"10","author":"IC Le Poole","year":"2008","unstructured":"Le Poole IC, Luiten RM. Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun. 2008;10:227\u201343.","journal-title":"Curr Dir Autoimmun"},{"issue":"3","key":"288_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65(3):473\u201391.","journal-title":"J Am Acad Dermatol"},{"key":"288_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/08916930108994127","volume":"34","author":"EH Kemp","year":"2001","unstructured":"Kemp EH, Waterman EA, Weetman AP. Autoimmune aspects of vitiligo. Autoimmunity. 2001;34:65\u201377.","journal-title":"Autoimmunity"},{"issue":"3","key":"288_CR13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1523-1747.2003.12413.x","volume":"121","author":"RL Mandelcorn-Monson","year":"2003","unstructured":"Mandelcorn-Monson RL, Shear NH, Yau E, Sambhara S, Barber BH, Spaner D, De Benedette MA. Cytotoxic T lymphocyte reactivity to gp100, MelanA\/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients. J Invest Dermatol. 2003 Sep;121(3):550\u20136.","journal-title":"J Invest Dermatol"},{"issue":"11\u201312","key":"288_CR14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1078\/0171-9335-00423","volume":"83","author":"J Steitz","year":"2004","unstructured":"Steitz J, Wenzel J, Gaffal E, Tuting T. Initiation and regulation of CD8 + T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. Eur J Cell Biol. 2004;83(11\u201312):797\u2013803.","journal-title":"Eur J Cell Biol"},{"issue":"6","key":"288_CR15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","volume":"97","author":"R Harning","year":"1991","unstructured":"Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol. 1991;97(6):1078\u201380.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"288_CR16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1468-3083.2005.01295.x","volume":"19","author":"S Farrokhi","year":"2005","unstructured":"Farrokhi S, Hojjat-Farsangi M, Noohpisheh MK, Tahmasbi R, Rezaei N. Assessment of the immune system in 55 Iranian patients with vitiligo. J Eur Acad Dermatol Venereol. 2005;19(6):706\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"288_CR17","unstructured":"Lotti T, D\u2019Erme AM, Hercogova J. The role of neuropeptides in the control of regional immunity. Clin Dermatol. (In press)."},{"issue":"4","key":"288_CR18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1152\/physrev.00026.2005","volume":"86","author":"D Roosterman","year":"2006","unstructured":"Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev. 2006;86(4):1309\u201379.","journal-title":"Physiol Rev"},{"key":"288_CR19","first-page":"160","volume":"131","author":"MSK Al","year":"1994","unstructured":"Al\u2019Abadie MSK, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol. 1994;131:160\u20135.","journal-title":"Br J Dermatol"},{"key":"288_CR20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1212\/WNL.20.10.965","volume":"20","author":"G Nellhiius","year":"1970","unstructured":"Nellhiius G, Acquired unilateral vitiligo and poliosis of the head and subacute encephalitis with partial recovery. Neurology. 1970;20:965\u201374.","journal-title":"Neurology"},{"issue":"3","key":"288_CR21","first-page":"163","volume":"73","author":"M. Silvan","year":"2004","unstructured":"Silvan M. The psychological aspects of vitiligo. Cutis. 2004;73(3):163\u20137.","journal-title":"Cutis"},{"issue":"6","key":"288_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-4632.2002.01408.x","volume":"41","author":"T Lotti","year":"2002","unstructured":"Lotti T, Bianchi B, Ghersetich I, Brazzini B, Hercogova J. Can the brain inhibit inflammation generated in the skin? The lesson of gamma-melanocyte-stimulating hormone. Int J Dermatol. 2002;41(6):311\u20138.","journal-title":"Int J Dermatol"},{"issue":"3","key":"288_CR23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0190-9622(95)91395-5","volume":"33","author":"T Lotti","year":"1995","unstructured":"Lotti T, Hautmann G, Panconesi E. Neuropeptides in skin. J Am Acad Dermatol. 1995;33(3):482\u201396.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"288_CR24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1365-4362.1999.00767.x","volume":"38","author":"T Lotti","year":"1999","unstructured":"Lotti T, Bianchi B, Panconesi E. Neuropeptides and skin disorders. The new frontiers of neuro-endocrine-cutaneous immunology. Int J Dermatol. 1999;38(9):673\u20135.","journal-title":"Int J Dermatol"},{"issue":"4","key":"288_CR25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.det.2005.05.021","volume":"23","author":"M Urpe","year":"2005","unstructured":"Urpe M, Pallanti S, Lotti T. Psychosomatic factors in dermatology. Dermatol Clin. 2005;23(4):601\u20138.","journal-title":"Dermatol Clin"},{"issue":"4","key":"288_CR26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.det.2005.05.017","volume":"23","author":"M Urpe","year":"2005","unstructured":"Urpe M, Buggiani G, Lotti T. Stress and psychoneuroimmunologic factors in dermatology. Dermatol Clin. 2005;23(4):609\u201317.","journal-title":"Dermatol Clin"},{"issue":"5","key":"288_CR27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/bjd.12162","volume":"168","author":"C Vrijman","year":"2013","unstructured":"Vrijman C, Hosseinpour D, Bakker JG, Wolkerstorfer A, Bos JD, van der Veen JP, Luiten RM. Provoking factors, including chemicals, in Dutch patients with vitiligo. Br J Dermatol. 2013;168(5):1003\u201311.","journal-title":"Br J Dermatol"},{"issue":"7","key":"288_CR28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1468-3083.2011.04171.x","volume":"26","author":"S Moretti","year":"2012","unstructured":"Moretti S, Arunachalam M, Colucci R, Pallanti S, Kline JA, Berti S, Lotti F, Lotti T. Autoimmune markers in vitiligo patients appear correlated with obsession and phobia. J Eur Acad Dermatol Venereol. 2012;26(7):861\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"288_CR29","doi-asserted-by":"crossref","unstructured":"D\u2019Erme AM, Zanieri F, Campolmi E, Santosuosso U, Betti S, Agnoletti AF, Cossidente A, Lotti T. Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective study. J Eur Acad Dermatol Venereol. 2012 Sep 11.","DOI":"10.1111\/j.1468-3083.2012.04690.x"},{"key":"288_CR30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-4362.1993.tb01442.x","volume":"32","author":"EM. Farber","year":"1993","unstructured":"Farber EM. Psychoneuroimmunology and dermatology. Int J Dermatol. 1993;32:93\u20134.","journal-title":"Int J Dermatol."},{"issue":"3","key":"288_CR31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1468-3083.2003.00792_6.x","volume":"17","author":"R Falabella","year":"2003","unstructured":"Falabella R, Barona MI, Echeverri IC, Alzate A. Substance P may play a part during depigmentation in vitiligo. A pilot study. J Eur Acad Dermatol Venereol. 2003 May;17(3):355\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"288_CR32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2006.12.012","volume":"265\u2013266","author":"A Slominski","year":"2007","unstructured":"Slominski A, Wortsman J, Tuckey RC, Paus R. Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol. 2007;265\u2013266:143\u20139.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"288_CR33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2004.09.007","volume":"25","author":"TC Theoharides","year":"2004","unstructured":"Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci. 2004;25(11):563\u20138.","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"288_CR34","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1096\/fj.00-0850rev","volume":"15","author":"A Slominski","year":"2001","unstructured":"Slominski A, Wortsman J, Pisarchik A, Zbytec B, Linton EA, Mazurkiewicz JE, Wei ET. Cutaneous expression of corticotrophin releasing hormone (CRH), urocortin and CRH receptors. FASEB J. 2001;15(10):1678\u201393.","journal-title":"FASEB J"},{"key":"288_CR35","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","volume":"84","author":"AT Slominski","year":"2004","unstructured":"Slominski AT, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004;84:1155\u2013228.","journal-title":"Physiol Rev"},{"issue":"2","key":"288_CR36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jdermsci.2007.06.004","volume":"48","author":"K Kingo","year":"2007","unstructured":"Kingo K, Aunin E, Karelson M, Philips MA, R\u00e4tsep R, Silm H, Vasar E, Soomets U, K\u00f5ks S. Gene expression analysis of melanocortin system in vitiligo. J Dermatol Sci. 2007;48(2):113\u201322.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"288_CR37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jdermsci.2010.08.004","volume":"60","author":"E Reimann","year":"2010","unstructured":"Reimann E, Kingo K, Karelson M, Salum T, Aunin E, Reemann P, Abram K, Vasar E, Silm H, K\u00f5ks S. Analysis of the expression profile of CRH-POMC system genes in vitiligo skin biopsies. J Dermatol Sci. 2010;60(2):125\u20138.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"288_CR38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/bja\/aet153","volume":"111","author":"M Al-Hashimi","year":"2013","unstructured":"Al-Hashimi M, Scott SW, Thompson JP, Lambert DG. Opioids and immune modulation: more questions than answers. Br J Anaesth. 2013;111(1):80\u20138.","journal-title":"Br J Anaesth"},{"key":"288_CR39","first-page":"53","volume":"54","author":"E Hristakieva","year":"2000","unstructured":"Hristakieva E, Lazarova R, Lazarov N, et al. Markers for vitiligo related neuropeptides in human skin nerve fibres. Acta Med Croatica. 2000;54:53\u20137.","journal-title":"Acta Med Croatica"},{"issue":"1","key":"288_CR40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ced.12164","volume":"39","author":"A Miniati","year":"2014","unstructured":"Miniati A, Weng Z, Zhang B, Therianou A, Vasiadi M, Nicolaidou E, Stratigos AJ, Antoniu C, Theoharides TC. Stimulated human melanocytes express and release interleukin-8, which is inhibited by luteolin: relevance to early vitiligo. Clin Exp Dermatol. 2014;39(1):54\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"288_CR41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/1523-1747.ep12874944","volume":"95","author":"TA Luger","year":"1990","unstructured":"Luger TA, Schwarz T. Evidence for an epidermal cytokine network. J Invest Dermatol. 1990;95:100\u20134.","journal-title":"J Invest Dermatol"},{"key":"288_CR42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0625.2007.00666_1.x","volume":"17","author":"KU Schallreuter","year":"2008","unstructured":"Schallreuter KU, Bahadoran P, Picardo M, et al. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol. 2008;17:139\u201340.","journal-title":"Exp Dermatol"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-014-0288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-014-0288-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-014-0288-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T07:18:13Z","timestamp":1649747893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-014-0288-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":42,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1007\/s10354-014-0288-7","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}